Wells Fargo’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.28M | Sell |
333,897
-99,845
| -23% | -$1.27M | ﹤0.01% | 2725 |
|
|
2025
Q4 | $3.9M | Sell |
433,742
-106,073
| -20% | -$1.46M | ﹤0.01% | 2906 |
|
|
2025
Q3 | $9.32M | Buy |
539,815
+301,387
| +126% | +$3.71M | ﹤0.01% | 2066 |
|
|
2025
Q2 | $2.24M | Sell |
238,428
-119,130
| -33% | -$978K | ﹤0.01% | 3140 |
|
|
2025
Q1 | $2.54M | Buy |
357,558
+79,866
| +29% | +$807K | ﹤0.01% | 2968 |
|
|
2024
Q4 | $3.24M | Buy |
277,692
+76,872
| +38% | +$1.2M | ﹤0.01% | 2797 |
|
|
2024
Q3 | $4.13M | Sell |
200,820
-837
| -0.4% | -$19.3K | ﹤0.01% | 2500 |
|
|
2024
Q2 | $4.51M | Sell |
201,657
-14,101
| -7% | -$336K | ﹤0.01% | 2341 |
|
|
2024
Q1 | $5.94M | Buy |
215,758
+13,164
| +6% | +$366K | ﹤0.01% | 2137 |
|
|
2023
Q4 | $6.18M | Sell |
202,594
-24,375
| -11% | -$701K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $7.18M | Buy |
226,969
+39,566
| +21% | +$1.53M | ﹤0.01% | 1842 |
|
|
2023
Q2 | $7.64M | Buy |
187,403
+24,003
| +15% | +$973K | ﹤0.01% | 1802 |
|
|
2023
Q1 | $6.09M | Buy |
163,400
+93,314
| +133% | +$3.66M | ﹤0.01% | 1974 |
|
|
2022
Q4 | $2.45M | Sell |
70,086
-13,938
| -17% | -$663K | ﹤0.01% | 2635 |
|
|
2022
Q3 | $4.7M | Buy |
84,024
+9,224
| +12% | +$572K | ﹤0.01% | 2043 |
|
|
2022
Q2 | $3.87M | Sell |
74,800
-24,342
| -25% | -$1.24M | ﹤0.01% | 2283 |
|
|
2022
Q1 | $7.21M | Sell |
99,142
-30,021
| -23% | -$2.54M | ﹤0.01% | 2124 |
|
|
2021
Q4 | $15.3M | Buy |
129,163
+700
| +0.5% | +$87.7K | ﹤0.01% | 1546 |
|
|
2021
Q3 | $17.2M | Buy |
128,463
+13,899
| +12% | +$2.1M | ﹤0.01% | 1770 |
|
|
2021
Q2 | $18.6M | Sell |
114,564
-11,351
| -9% | -$884K | ﹤0.01% | 1733 |
|
|
2021
Q1 | $10.1M | Sell |
125,915
-28,846
| -19% | -$1.94M | ﹤0.01% | 2185 |
|
|
2020
Q4 | $8.42M | Buy |
154,761
+88,173
| +132% | +$3.2M | ﹤0.01% | 2238 |
|
|
2020
Q3 | $1.32M | Sell |
66,588
-43,787
| -40% | -$913K | ﹤0.01% | 3647 |
|
|
2020
Q2 | $2.32M | Buy |
110,375
+29,648
| +37% | +$504K | ﹤0.01% | 3152 |
|
|
2020
Q1 | $988K | Buy |
80,727
+18,857
| +30% | +$254K | ﹤0.01% | 3557 |
|
|
2019
Q4 | $907K | Buy |
61,870
+6,684
| +12% | +$93K | ﹤0.01% | 3920 |
|
|
2019
Q3 | $737K | Buy |
55,186
+2,972
| +6% | +$47.4K | ﹤0.01% | 4083 |
|
|
2019
Q2 | $855K | Buy |
52,214
+5,802
| +13% | +$91.2K | ﹤0.01% | 3974 |
|
|
2019
Q1 | $792K | Buy |
46,412
+12,560
| +37% | +$187K | ﹤0.01% | 4047 |
|
|
2018
Q4 | $462K | Sell |
33,852
-28,894
| -46% | -$537K | ﹤0.01% | 4383 |
|
|
2018
Q3 | $1.8M | Sell |
62,746
-8,627
| -12% | -$251K | ﹤0.01% | 3504 |
|
|
2018
Q2 | $1.95M | Sell |
71,373
-7,585
| -10% | -$184K | ﹤0.01% | 3472 |
|
|
2018
Q1 | $1.66M | Buy |
78,958
+44,191
| +127% | +$1.09M | ﹤0.01% | 3519 |
|
|
2017
Q4 | $668K | Buy |
34,767
+18,050
| +108% | +$417K | ﹤0.01% | 4190 |
|
|
2017
Q3 | $415K | Sell |
16,717
-13,498
| -45% | -$254K | ﹤0.01% | 4442 |
|
|
2017
Q2 | $483K | Buy |
30,215
+19,270
| +176% | +$269K | ﹤0.01% | 4239 |
|
|
2017
Q1 | $154K | Buy |
10,945
+7,645
| +232% | +$103K | ﹤0.01% | 4969 |
|
|
2016
Q4 | $42K | Buy |
3,300
+900
| +38% | +$13.5K | ﹤0.01% | 5425 |
|
|
2016
Q3 | $41K | Hold |
2,400
| – | – | ﹤0.01% | 5378 |
|
|
2016
Q2 | $51K | Buy |
+2,400
| New | +$63.9K | ﹤0.01% | 5195 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
